{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:48:17Z","timestamp":1789692497578,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,10]]},"DOI":"10.7759\/cureus.37385","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T16:26:31Z","timestamp":1681143991000},"source":"Crossref","is-referenced-by-count":4,"title":["Phenotype and Genotype of Saudi Pediatric Patients With Neurofibromatosis Type 1: A Seven-Year Multicenter Experience From Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Mohammed A","family":"Alfurayh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf K","family":"Alawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz M","family":"Bin Akrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awad S","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sharahili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz S","family":"Bin Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad  T","family":"Alrifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64076-5.00051-X","article-title":"Neurofibromatosis type 1","volume":"148","author":"Cimino PJ","year":"2018","unstructured":"Cimino PJ, Gutmann DH. Neurofibromatosis type 1. Handb Clin Neurol. 2018, 148:799-811. 10.1016\/B978-0-444-64076-5.00051-X","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales","volume":"111 ( Pt 6)","author":"Huson SM","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988, 111 ( Pt 6):1355-81. 10.1093\/brain\/111.6.1355","journal-title":"Brain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe AC","year":"2014","unstructured":"Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014, 13:834-43. 10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace MR","year":"1990","unstructured":"Wallace MR, Marchuk DA, Andersen LB, et al.. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990, 249:181-6. 10.1126\/science.2134734","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau GA","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, et al.. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993, 363:515-21. 10.1038\/363515a0","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/513207","article-title":"Germline mutation of INI1\/SMARCB1 in familial schwannomatosis","volume":"80","author":"Hulsebos TJ","year":"2007","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007, 80:805-10. 10.1086\/513207","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.215","article-title":"Prevalence of neurofibromatosis type 1 in the Finnish population","volume":"20","author":"Kallionp\u00e4\u00e4 RA","year":"2018","unstructured":"Kallionp\u00e4\u00e4 RA, Uusitalo E, Lepp\u00e4virta J, P\u00f6yh\u00f6nen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the Finnish population. Genet Med. 2018, 20:1082-6. 10.1038\/gim.2017.215","journal-title":"Genet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann DH","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017, 3:17004. 10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7417\/CT.2020.2242","article-title":"Cutaneous manifestations in neurofibromatosis type 1","volume":"171","author":"Miraglia E","year":"2020","unstructured":"Miraglia E, Moliterni E, Iacovino C, Roberti V, Laghi A, Moramarco A, Giustini S. Cutaneous manifestations in neurofibromatosis type 1. Clin Ter. 2020, 171:e371-7. 10.7417\/CT.2020.2242","journal-title":"Clin Ter"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2019.09.025","article-title":"Lisch nodules in neurofibromatosis type 1 [Article in French]","volume":"43","author":"Haddar S","year":"2020","unstructured":"Haddar S, Mahjoub A, Ben Abdesslem N, Ben Mrad S, Knani L, Mahjoub H. Lisch nodules in neurofibromatosis type 1 [Article in French]. J Fr Ophtalmol. 2020, 43:559-60. 10.1016\/j.jfo.2019.09.025","journal-title":"J Fr Ophtalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32834230ce","article-title":"Orthopaedic aspects of neurofibromatosis: update","volume":"23","author":"Delucia TA","year":"2011","unstructured":"Delucia TA, Yohay K, Widmann RF. Orthopaedic aspects of neurofibromatosis: update. Curr Opin Pediatr. 2011, 23:46-52. 10.1097\/MOP.0b013e32834230ce","journal-title":"Curr Opin Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234976","article-title":"Neurofibromatosis-associated pulmonary hypertension: an ominous duo","volume":"13","author":"Coelho SG","year":"2020","unstructured":"Coelho SG, Loureiro MJ. Neurofibromatosis-associated pulmonary hypertension: an ominous duo. BMJ Case Rep. 2020, 13:e234976. 10.1136\/bcr-2020-234976","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0588-2","article-title":"Non-optic glioma in adults and children with neurofibromatosis 1","volume":"12","author":"Sellmer L","year":"2017","unstructured":"Sellmer L, Farschtschi S, Marangoni M, et al.. Non-optic glioma in adults and children with neurofibromatosis 1. Orphanet J Rare Dis. 2017, 12:34. 10.1186\/s13023-017-0588-2","journal-title":"Orphanet J Rare Dis"},{"key":"ref14","article-title":"Optic pathway glioma and cerebral focal abnormal signal intensity in patients with neurofibromatosis type 1: characteristics, treatment choices and follow-up in 134 affected individuals and a brief review of the literature","volume":"36","author":"Friedrich RE","year":"2016","unstructured":"Friedrich RE, Nuding MA. Optic pathway glioma and cerebral focal abnormal signal intensity in patients with neurofibromatosis type 1: characteristics, treatment choices and follow-up in 134 affected individuals and a brief review of the literature. Anticancer Res. 2016, 36:4095-121.","journal-title":"Anticancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/a-1816-8746","article-title":"The utility of early brain MRI for patients with neurofibromatosis type 1 and optic pathway glioma: a long-term follow-up in a tertiary referral hospital","volume":"53","author":"Rony C","year":"2022","unstructured":"Rony C, Aharoni S, Halevy A. The utility of early brain MRI for patients with neurofibromatosis type 1 and optic pathway glioma: a long-term follow-up in a tertiary referral hospital. Neuropediatrics. 2022, 53:370-5. 10.1055\/a-1816-8746","journal-title":"Neuropediatrics"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2015.12.002","article-title":"Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort","volume":"20","author":"Blanchard G","year":"2016","unstructured":"Blanchard G, Lafforgue MP, Lion-Fran\u00e7ois L, et al.. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Eur J Paediatr Neurol. 2016, 20:275-81. 10.1016\/j.ejpn.2015.12.002","journal-title":"Eur J Paediatr Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061426","article-title":"Retrospective multicentric study on non-optic CNS tumors in children and adolescents with neurofibromatosis type 1","volume":"12","author":"Santoro C","year":"2020","unstructured":"Santoro C, Picariello S, Palladino F, et al.. Retrospective multicentric study on non-optic CNS tumors in children and adolescents with neurofibromatosis type 1. Cancers (Basel). 2020, 12:1426. 10.3390\/cancers12061426","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1017\/s0317167100004017","article-title":"Neurofibromatosis type 1 in a pediatric population: Ste-Justine's experience","volume":"32","author":"Boulanger JM","year":"2005","unstructured":"Boulanger JM, Larbrisseau A. Neurofibromatosis type 1 in a pediatric population: Ste-Justine's experience. Can J Neurol Sci. 2005, 32:225-31. 10.1017\/s0317167100004017","journal-title":"Can J Neurol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000169","article-title":"Neurofibromatosis-related tumors: emerging biology and therapies","volume":"27","author":"Karajannis MA","year":"2015","unstructured":"Karajannis MA, Ferner RE. Neurofibromatosis-related tumors: emerging biology and therapies. Curr Opin Pediatr. 2015, 27:26-33. 10.1097\/MOP.0000000000000169","journal-title":"Curr Opin Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd KP","year":"2009","unstructured":"Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol. 2009, 61:1-14; quiz 15-6. 10.1016\/j.jaad.2008.12.051","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans DG","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002, 39:311-4. 10.1136\/jmg.39.5.311","journal-title":"J Med Genet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0589","article-title":"Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1","volume":"23","author":"Evans DG","year":"2017","unstructured":"Evans DG, Salvador H, Chang VY, et al.. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res. 2017, 23:e46-53. 10.1158\/1078-0432.CCR-17-0589","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121838","article-title":"Risk of optic pathway glioma in neurofibromatosis type 1: no evidence of genotype-phenotype correlations in a large independent cohort","volume":"11","author":"Melloni G","year":"2019","unstructured":"Melloni G, Eoli M, Cesaretti C, et al.. Risk of optic pathway glioma in neurofibromatosis type 1: no evidence of genotype-phenotype correlations in a large independent cohort. Cancers (Basel). 2019, 11:1838. 10.3390\/cancers11121838","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12625","article-title":"Neurofibromatosis type 1 and malignancy in childhood","volume":"89","author":"Varan A","year":"2016","unstructured":"Varan A, \u015een H, Ayd\u0131n B, Yal\u00e7\u0131n B, Kutluk T, Aky\u00fcz C. Neurofibromatosis type 1 and malignancy in childhood. Clin Genet. 2016, 89:341-5. 10.1111\/cge.12625","journal-title":"Clin Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003881","article-title":"A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1","volume":"88","author":"Mahdi J","year":"2017","unstructured":"Mahdi J, Shah AC, Sato A, et al.. A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology. 2017, 88:1584-9. 10.1212\/WNL.0000000000003881","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-010-1163-5","article-title":"Posterior fossa tumors in children with neurofibromatosis type 1 (NF1)","volume":"26","author":"Pascual-Castroviejo I","year":"2010","unstructured":"Pascual-Castroviejo I, Pascual-Pascual SI, Via\u00f1o J, Carceller F, Gutierrez-Molina M, Morales C, Frutos-Martinez R. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst. 2010, 26:1599-603. 10.1007\/s00381-010-1163-5","journal-title":"Childs Nerv Syst"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1742197","article-title":"Prevalence of associated endocrine diseases in patients with neurofibromatosis type 1","volume":"12","author":"Alshahrani A","year":"2022","unstructured":"Alshahrani A, Abuoliat Z, Alshahrani AS, Al Balwi MA. Prevalence of associated endocrine diseases in patients with neurofibromatosis type 1. Avicenna J Med. 2022, 12:16-20. 10.1055\/s-0041-1742197","journal-title":"Avicenna J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01373","article-title":"Can the cognitive phenotype in neurofibromatosis type 1 (NF1) be explained by neuroimaging? A review","volume":"10","author":"Baudou E","year":"2019","unstructured":"Baudou E, Nemmi F, Biotteau M, Maziero S, Peran P, Chaix Y. Can the cognitive phenotype in neurofibromatosis type 1 (NF1) be explained by neuroimaging? A review. Front Neurol. 2019, 10:1373. 10.3389\/fneur.2019.01373","journal-title":"Front Neurol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1517\/17530059.2010.494660","article-title":"Neurofibromatosis type 1: diagnosis and recent advances","volume":"4","author":"Upadhyaya M","year":"2010","unstructured":"Upadhyaya M. Neurofibromatosis type 1: diagnosis and recent advances. Expert Opin Med Diagn. 2010, 4:307-22. 10.1517\/17530059.2010.494660","journal-title":"Expert Opin Med Diagn"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1631","article-title":"Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1","volume":"9","author":"Abdel-Aziz NN","year":"2021","unstructured":"Abdel-Aziz NN, El-Kamah GY, Khairat RA, Mohamed HR, Gad YZ, El-Ghor AM, Amr KS. Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1. Mol Genet Genomic Med. 2021, 9:e1631. 10.1002\/mgg3.1631","journal-title":"Mol Genet Genomic Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/148357-phenotype-and-genotype-of-saudi-pediatric-patients-with-neurofibromatosis-type-1-a-seven-year-multicenter-experience-from-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:08Z","timestamp":1707508688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/148357-phenotype-and-genotype-of-saudi-pediatric-patients-with-neurofibromatosis-type-1-a-seven-year-multicenter-experience-from-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.37385","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,10]]}}}